RBA
WST icon

Richard Bernstein Advisors’s West Pharmaceutical WST Stock Holding History

Richard Bernstein Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,831
Closed -$4.48M – 328
2020
Q4 		$4.48M Hold
15,831
– – 0.11% 99
2020
Q3 		$4.35M Hold
15,831
– – 0.12% 81
2020
Q2 		$3.6M Sell
15,831
-16,758
-51% -$3.29M 0.11% 102
2020
Q1 		$4.96M Hold
32,589
– – 0.18% 63
2019
Q4 		$4.9M Hold
32,589
– – 0.16% 92
2019
Q3 		$4.62M Hold
32,589
– – 0.15% 98
2019
Q2 		$4.08M Hold
32,589
– – 0.14% 113
2019
Q1 		$3.59M Buy
+32,589
New +$3.39M 0.12% 149

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Richard Bernstein Advisors's WST Position: Q1 2021 in Review

Richard Bernstein Advisors sold out of West Pharmaceutical (WST) in Q1 2021, closing a stake of 15,831 shares — an estimated $4.48M sold.

Richard Bernstein Advisors first reported a position in WST in Q1 2019 and held it in 8 quarters. The position peaked at $4.96M in Q1 2020. 590 funds tracked by Wall St. Rank hold WST as of Q1 2021.

  • Richard Bernstein Advisors reported no remaining West Pharmaceutical position as of Q1 2021 after selling out during the quarter.
  • Richard Bernstein Advisors sold 15,831 West Pharmaceutical shares in Q1 2021, an estimated $4.48M.
  • Richard Bernstein Advisors first reported a position in West Pharmaceutical in Q1 2019 and held it in 8 quarters.
  • Richard Bernstein Advisors's West Pharmaceutical position peaked at $4.96M in Q1 2020.
  • 590 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2021.

Based on Richard Bernstein Advisors's 13F filing for Q1 2021, filed 14 May 2021.